<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Over 400 cases of pediatric SAA occur annually in the United States </plain></SENT>
<SENT sid="1" pm="."><plain>A growing number of children with SAA may have had their stem cells harvested through cord blood collection </plain></SENT>
<SENT sid="2" pm="."><plain>We describe a nine-yr-old male with SAA treated successfully with an autologous cord blood transplant following immunoablative chemotherapy </plain></SENT>
<SENT sid="3" pm="."><plain>With the increasing number of people cryopreserving autologous cord blood, the use of autologous cord blood in the treatment of SAA might be considered as initial therapy </plain></SENT>
<SENT sid="4" pm="."><plain>This case serves to discuss approaches to preparative therapy as well as the potential complications in this growing cohort of patients </plain></SENT>
</text></document>